The New York State Racing and Wagering Board has disciplined a trainer, assistant trainer, and veterinarian for two tranquilizers found in the system of Vagabond Saint following a second-place finish in the second race at Aqueduct April 14.
The Indiana Horse Racing Commission April 21 called for an economic impact study on the impact of having--or not having--Kentucky signals available at the state's racetracks and off-track betting parlors.
The Kentucky Horse Racing Authority is moving forward with renewal of an equine drug-testing contract with Iowa State University pending review of the document by the state Finance Cabinet and assurances test results will be expedited.
Officials gathered in New Orleans for the first Joint Conference of Racing Regulators will consider a proposed national medication policy that calls for voluntary use of Salix on race days and use of one of three non-steroidal anti-inflammatory drugs no later than 24 hours before a race.
The Thoroughbred Owners and Breeders Association remains committed to implementing a drug-testing program tied to the American Graded Stakes Committee by July 1, an official said April 1 during the Joint Conference of Racing Regulators in New Orleans.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
The National Horsemen's Benevolent and Protective Association has adopted a position paper on medication and drug-testing that says any changes in policies in each jurisdiction should be enacted only after there is scientific evidence specific therapeutic drugs shouldn't be used in racehorses.
The Racing Medication and Testing Consortium has approved policy language on race-day use of Salix and non-steroidal anti-inflammatory drugs, as well as environmental contaminants, and also formed a subcommittee to review race-day security practices.
Though the Kentucky Racing Commission has been abolished and replaced by the Kentucky Horse Racing Authority, the Kentucky Equine Drug Research Council apparently remains in place--but not necessarily intact.
The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
Jockeys at Philadelphia Park voted not to ride the 10-race card Dec. 29 after they were unable to resolve payroll issues with management.
The American Graded Stakes Committee, which is administered by the Thoroughbred Owners and Breeders Association, will implement its plan of stringent drug testing for all graded stakes beginning in July 2004.
The perception of wrongdoing in racing is strong enough that regulators and marketers must not dismiss it, officials said Dec. 11 during a panel discussion titled "The Changing Environment of Regulation" at the University of Arizona Symposium on Racing.
The Racing Medication and Testing Consortium continued its march toward a national model policy on medication and drug testing Dec. 10 when regulators responded favorably to the proposal. But wholesale changes in race-day medication rules around the country aren't expected to take place any time soon.
Regulators in the United States will get their first look at a proposed national medication and drug-testing policy Dec. 10, but even if it wins widespread support, it could take some time before any changes are enacted in various jurisdictions.
Industry officials, during a preliminary meeting Dec. 2 at Philadelphia Park, discussed testing for erythropoietin antibodies that could be implemented in Pennsylvania and perhaps a few other Mid-Atlantic states in 2004.
Though regulators on Dec. 10 will examine a proposal for a national medication and drug-testing policy, release of the document to the public hinges on how well it is received during the meeting.
The debate over whether Kentucky should implement a restrictive race-day medication policy heated up Nov. 18 with calls by racetrack veterinarians and trainers to keep the current policy intact, and allegations that the national Racing Medication and Testing Consortium is carrying out an agenda in secret.
The racing commissions that govern Thoroughbred and Standardbred racing in Delaware have been testing for erythropoietin antibodies since June 1, and in the future may implement rules to penalize horses that test positive.
New York regulators Oct. 21 gave final approval to a new rule authorizing the testing of post-race samples for performance-enhancing erythropoetin antibodies. The New York Racing and Wagering Board said the testing would begin Nov. 1, which would make New York the first state to require the test.
Oak Tree Racing Association has stepped up backstretch security for its current meet, which includes the Breeders' Cup World Thoroughbred Championships on Oct. 25 at Santa Anita Park.
The Kentucky Racing Commission has approved extensive drug testing in conjunction with the American Graded Stakes Committee mandate that it be implemented in order for stakes to retain their grades.
The chairman of the Kentucky Racing Commission has advocated a Salix-only policy on race day in the state, and said he would schedule meetings around the state to get feedback. Currently, five medications are permitted on race day in Kentucky.
The Racing Medication and Testing Consortium has made substantial progress on a model policy for the horse racing industry and also has allocated $275,000 for four research projects tied to its initiatives.
The Kentucky Racing Commission and the Kentucky Equine Drug Council in October will consider the mandate by the American Graded Stakes Committee that enhanced drug testing be implemented by next year in order for stakes to maintain their grades.
The Breeders' Cup board of directors on Monday officially endorsed the proposed Thoroughbred Championship Tour, and also said it would use a new drug-testing protocol being designed by the Thoroughbred Owners and Breeders Association for all graded stakes.
John Roark, president of the Texas Horsemen's Partnership and a board member of the National Thoroughbred Racing Association, fought back a challenge to win a second two-year term as president of the National Horsemen's Benevolent and Protective Association.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
With a goal to raise $2 million to $3 million a year to support its initiatives, the Racing Medication and Testing Consortium is looking at a mechanism that would raise money from horsemen and racetracks based on the top four finishers in each race.
Participants in a July 10 medication workshop reached the consensus that "over-medication" may contribute to fewer starts by racehorses, but other factors -- racetrack surfaces, an emphasis on speed, too much pressure on 2-year-olds, and a thirst for quick profit -- probably are just as responsible.
The board of directors of the Association of Racing Commissioners International will consider adoption of a policy that would make treatments such as hypoxic therapy prohibited practices until their impact on horses is scientifically demonstrated.
The American Graded Stakes Committee plans to install a drug testing protocol for all graded stakes in 2004 that will require laboratories to perform tests for approximately 140 parent drugs and their analytes.
The Kentucky Racing Commission has approved an agreement with the University of Kentucky for the college to apply for accreditation of its Animal Drug Testing Program and better monitor projects and control related costs.
Mid-Atlantic regulators and the Thoroughbred Horsemen's Association are scheduled to meet June 12 in New Jersey to discuss medication and drug-testing issues on a regional and national scope.
The American Graded Stakes Committee will begin implementing a drug-testing plan for horses participating in its designated races beginning at Keeneland and Belmont Park this fall. It expects to have the testing protocol fully in place by the end of 2004.
Say Florida Sandy, the all-time leading New York-bred in terms of earnings, has been placed first in the Jan. 25 Paumonok Handicap at Aqueduct because of the disqualification of Crossing Point for a clenbuterol positive after a post-race urine test.
The largest out-of-competition drug-testing raid in Australian history Monday at Randwick racecourse produced no positive tests. The practice was introduced in Australia last October.
Uniformity in medication and drug testing could be years away, a member of the Racing Medication and Testing Consortium said April 1 during a California Horse Racing Board Medication Committee meeting.
California has taken the first step to ban the backstretch use of snake venom, which officials believe can be used as a nerve- or joint-numbing agent in sore or injured horses.
The Thoroughbred Corp.'s Kafwain was disqualified from his second-place finish in the March 9 Louisiana Derby at Fair Grounds because he raced with an excessive amount of the bronchodilator clenbuterol. Trainer Bob Baffert did not appeal so Kafwain could make his next racing engagement, but he has called for uniformity in medication rules.
Four of five Standardbred trainers under investigation for illegally administering oxycodone to racehorses were exonerated when split samples showed no traces of the painkiller in urine taken from original samples that tested positive.
The chairman of the Kentucky Racing Commission says an investigation of a personal services contract awarded for a review of drug research is an attack on the racing commission and Thoroughbred industry in the state.
The first joint meeting of the boards of the Thoroughbred Racing Associations and Harness Tracks of America was considered a success, but whether the two organizations continue to meet jointly on a regular basis remains to be seen.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.
Two bills that would permit officials in Kentucky to spend money on equine drug research out of state were withdrawn from consideration in the state House of Representatives.
Antibodies for erythropoeitin, a blood-doping substance commonly known as EPO, were found in six racehorses at Sam Houston Race Park, the Dallas Morning News reported Feb. 18.
Aqueduct-based trainer Gary Contessa is awaiting his fate on a slew of ephedra positives that have sidetracked his operation.
The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.
The Racing Medication and Testing Consortium is scheduled to meet Feb. 4 in Atlanta, Ga., to hammer out details of its structure and further develop its policy statement.
Most Popular Stories
- The Great War No Longer Pursuing Derby
- Field Favored at Close of Derby Wager Pool 3
- Rebel Still Possibilty for Take Charge Brandi
- Far From Over Interest Sold, Wood Next
- Dortmund, Lord Nelson Set for San Felipe
- The Big Beast Sharp in Winning Return
- Daredevil Still Ready for Rescheduled Swale
- Cavalryman Dies After Injury at Meydan
- El Kabeir Breezes for Gotham
- French Group I Winner Creator Dies at 29